業績

2012年度 :: 著書・雑誌 :: 英文 :: 原著 :: 業績

Clinical outcome of japanese metastatic colorectal cancer patients harbouring the KRAS p.G13D mutation treated with cetuximab + irinotecan.

Bando H, Yoshino T, Yuki S, Shinozaki E, Nishina T, Kadowaki S, Yamazaki K, Kajiura S, Tsuchihara K, Fujii S, Yamanaka T, Ohtsu A.

Jpn J Clin Oncol. 2012; 42(12): 1146-1151

Human equilibrative nucleoside transporter 1 and Notch3 can predict gemcitabine effects in patients with unresectable pancreatic cancer.

Eto K, Kawakami H, Kuwatani M, Kudo T, Abe Y, Kawahata S, Takasawa A, Fukuoka M, Matsuno Y, Asaka M, Sakamoto N.

Br J Cancer. 2013; 108(7): 1488-1494

Inhibition of both protease and helicase activities of hepatitis C virus NS3 by an ethyl acetate extract of marine sponge Haliclona (Reniera) sp.

Fujimoto Y, Salam KA, Furuta A, Matsuda Y, Fujita O, tani H, Ikeda M, Kato N, Sakamoto N, Maekawa S, Enomoto N, de Voogd NJ, Nakakoshi M, Tsubuki M, Sekiguchi Y, Tsuneda S, Akimitsu N, Noda N, Yamashita A, Tanaka J, Moriishi K.

PLoS One. 2012; 7(11): e48685

A large-scale nationwide multicenter prospective observational study of triple therapy using rabeprazole,amoxicillin,and clarithromycin for Helicobacter pylori eradication in Japan.

Fujioka T. Aoyama N, Sakai K, Miwa Y, Kudo M, Kawashima J, Matsubara Y, Miwa J, Yakabi K.

J Gastroenterol. 2012; 47: 276-283

Identification of a high risk gastric cancer group using serum pepsinogen after successful eradication of Helicobacter pylori.

Haneda M, Kato M, Ishigaki S, Suzuki M, Takahashi M, Nakagawa M, Ono S, Mori Y, Mabe K, Nakagawa S, Kudo T, Shimizu Y, Asaka M.

J Gastroenterol Hepatol. 2013; 28(1): 78-83

Prospective clinical study of endoscopic ultrasound-guided choledochoduodenostomy with direct metallic stent placement using a forward-viewing echoendoscope.

Hara K, Yamao K, Hijioka S, Mizuno N, Imaoka H, Tajika M, Kondo S, Tanaka T, Haba S, Takeshi O, Nagashio Y, Obayashi T, Shinagawa A, Bhatia V, Shimizu Y, Goto H, Niwa Y.

Endoscopy. 2013; 45(5): 392-396

Comparison of gastric relaxation and sensory functions between functional dyspepsia and healthy subjects using novel drink-ing-Ultrasonography test.

Hata T, Kato M, Kudo T, Nishida M, Nisida U, Imai A, Yoshida T, Hirota J, Kamada G, Ono S, Nakagawa M, Nakagawa S, Shimizu Y, Takeda H, Asaka M.

Digestion. 2013; 87(1): 34-39

Diagnostic yield of endoscopic retrograde cholangiography and of EUS-guided fine needle aspiration sampling in gallbladder car-cinomas.

Hijioka S, Hara K, Mizuno N, Imaoka H, Ogura T, Haba S, Mekky MA, Bhatia V, Hosoda W, Yatabe Y, Shimizu Y, Niwa Y, Tajika M, Kondo S, Tanaka T, Tamada K, Yamao K.

J Hepatobiliary Pancreat Sci. 2012; 19(6): 650-655

Efficacy of carbon dioxide-insufflating colonoscopy in patients with irritable bowel syndrome (IBS): a randomized double-blind study.

Imai A, Kato M, Ono S, Shimizu Y, Takeda H, Asaka M.

J Gastroenterol Hepatol. 2012; 27(10): 1623-1628

Evaluation of effects of a novel endoscopically applied radiofrequency ablation biliary catheter using an ex-vivo pig liver.

Itoi T, Isayama H, Sofuni A, Itokawa F, Tamura M, Watanabe Y, Moriyasu F, Kahaleh M, Habib N, Nagao T, Yokoyama T, Kasuya K, Kawakami H.

J Hepatobiliary Pancreat Sci. 2012; 19(5): 543-547

Isolation and characterization of mouse and human esophageal epithelial cells in 3D organotypic culture.

Kalabis J, Wong GS, Vega ME, Natsuizaka M, Robertson ES, Herlyn M, Nakagawa H, Rustgi AK.

Nature Protoc. 2012; 7(2): 235-246

Adjuvant therapy with imatinib mesylate after resection of primary high-risk gastrointestinal stromal tumors in Japanese patients.

Kanda T, Nishida T, Wada N, Kobayashi O, Yamamoto M, Sawaki A, Boku N, Koseki M, Doi T, Toh Y, Kakeji Y, Sugiyama T, Komatsu Y, Kikuchi S, Ogoshi K, Katai H, Miyachi K, Hirota S, Ohtsu A.

Int J Clin Oncol. 2013; 18(1): 38-45

Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir.

Karino Y, Toyota J, Ikeda K, Suzuki F, Chayama K, Kawakami Y, Ishikawa H, Watanabe H, Hernandez D, Yu F, McPhee F, Kumada H.

J Hepatol. 2012; 58(4): 646-654

Decrease of peripheral and intestinal NKG2A-positive T cells in patients with ulcerative colitis.

Katsurada T, Kobayashi W, Tomaru U, Baba T, Furukawa S, Ishizu A, Takeda K, Sakamoto N, Asaka M, Takeda H, Kasahara M.

PLoS One. 2012; 7(9): e44113

KRAS mutations in primary tumours and post-FOLFOX metastatic lesions in cases of colorectal cancer.

Kawamoto Y, Tsuchihara K, Yoshino T, Ogasawara N, Kojima M, Takahashi M, Ochiai A, Bando H, Fuse N, Tahara M, Doi T, Esumi H, Komatsu Y, Ohtsu A.

Br J Cancer. 2012; 107(2): 340-344

Anemia and thrombocytosis induced by ribavirin monotherapy in patients with chronic hepatitis C.

Kobayashi T, Hige S, Terashita K, Nakai M, Horimoto H, Sho T, Nakanishi M, Ogawa K, Chuma M, Sakamoto N, Asaka M.

J Gastroenterol. 2012; 47(11): 1228-1237

Add-on therapy of pitavastatin and eicosapentaenoic acid improves outcome of peginterferon plus ribavirin treatment for chronic hepatitis C.

Kohjima M, Enjoji M, Yoshimoto T, Yada R, Fujino T, Aoyagi Y, Fukushima N, Fukuizumi K, Harada N, Yada M, Kato M, Kotoh K, Nakashima M, Sakamoto N, Tanaka Y, Nakamuta M.

J Med Virol. 2013; 85(2): 250-260

Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer.

Komatsu Y, Yuki S, Sogabe S, Fukushima H, Nakatsumi H, Kobayashi Y, Iwanaga I, Nakamura M, Hatanaka K, Miyagishima T, Kudo M, Munakata M, Meguro T, Tateyama M, Sakata Y.

Acta Oncol. 2012; 51(7): 867-872

A model incorporating the ITPA genotype identifies patients at high risk of anemia and treatment failure with pegylated-interferon plus ribavirin therapy for chronic hepatitis C.

Kurosaki M, Tanaka Y, Nishida N, Sakamoto N, Enomoto N, Matsuura K, Asahina Y, Nakagawa M, Watanabe M, Sakamoto M, Maekawa S, Tokunaga K, Mizokami M, Izumi N.

J Med Virol. 2013; 85(3): 449-458

Cyclophilin A and nuclear factor of activated T cells are essential in cyclosporin A-mediated suppression of polyomavirus BK rep-lication.

Li YJ, Wu HH, Weng CH, Chen YC, Hung CC, Yang CW, Wang YL, Sakamoto N, Tian YC.

Am J Transpl. 2012; 12(9): 2348-2362

Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, pla-cebo-controlled trial.

Miki K, Maekura R, Nagaya N, Nakazato M, Kimura H, Murakami S, Ohnishi S, Hiraga T, Miki M, Kitada S, Yoshimura K, Tateishi Y, Arimura Y, Matsumoto N, Yoshikawa M, Yamahara K, Kangawa K.

PLoS One. 2012; 7(5): e35708

Phase I dose-escalating study of panobinostat (LBH589) administered intravenously to Japanese patients with advanced solid tumors.

Morita S, Oizumi S, Minami H, Kitagawa K, Komatsu Y, Fujiwara Y, Inada M, Yuki S, Kiyota N, Mitsuma A, Sawaki M, Tanii H, Kimura J, Ando Y.

Invest New Drugs. 2012; 30(5): 1950-1957

Genetic Notch inhibition reveals cyclin D1 and Wnt signaling in invasive esophageal squamous cell carcinoma.

Naganuma S, Whelan KA, Natsuizaka M, Kagawa S, Kinugasa H, Chang S, Subramanian H, Rhoades B, Ohashi S, Itoh H, Herlyn M, Diehl JA, Gimotty PA, Klein-Szanto AJ, Nakagawa H.

Am J Cancer Res. 2012; 2(4): 459-474

Impaired ghrelin signaling is associated with gastrointestinal dusmotility in rats with gastroesophageal reflux disease.

Nahata M, Muto S, Oridate N, Ohnishi S, Nakagawa K, Sadakane C, Saegusa Y, Hattori T, Asaka M, Takeda H.

Am J Physiol Gastrointest Liver Physiol. 2012. 303(1): G42-G53

The nuclear protein Artemis promotes AMPK activation by stabilizing the LKB1-AMPK complex.

Nakagawa K, Uehata Y, Natsuizaka M, Kohara T, Darmanin S, Asaka M, Takeda H, Kobayashi M.

Biochem Biophys Res Commun. 2012; 427(4): 790-795

Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.

Nakamura S, Sugiyama T, Matsumoto T, Iijima K, Ono S, Tajika M, Tari A, Kitadai Y, Matsumoto H, Nagaya T, Kamoshida T, Watanabe N, Chiba T, Origasa H, Asaka M; Japan GAST Study Group.

Gut. 2012; 61(4): 507-513

Relationship between diffusion-weighted magnetic resonance imaging and histological tumor grading of hepatocellular carcinoma.

Nakanishi M, Chuma M, Hige S, Omatsu T, Yokoo H, Nakanishi K, Kamiyama T, Kubota K, Haga H, Matsuno Y, Onodera Y, Kato M, Asaka M.

Ann Surg Oncol. 2012; 19(4): 1302-1309

Optimal dose period for indisetron tablets for preventing chemotherapy-induced nausea and vomiting with modified FOLFOX6: A randomized pilot study.

Nakatsumi H, Komatsu Y, Yuki S, Sogabe S, Tateyama M, Muto S, Kudo M, Kato K, Miyagishima T, Uebayashi M, Meguro T, Oba K, Asaka M.

Chemotherapy. 2012; 58(6): 439-444

Hypoxia induces IGFBP3 expression in esophageal squamous cancer cells through polysome-enriched HIF-1α mediated mRNA transcription and continuous protein synthesis.

Natsuizaka M, Naganuma S, Kagawa S, Ohashi S, Ahmadi A, Subramanian H, Chang S, Nakagawa K, Ji X, Liebhaber SA, Klein-Szanto AJ, Nakagawa H.

FASEB J. 2012; 26(6): 2620-2630

Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type-I interferon-dependent innate immunity.

Nitta S, Sakamoto N, Nakagawa M, Kakinuma S, Mishima K, Kusano-Kitazume A, Kiyohashi K, Murakawa M, Nishimura-Sakurai Y, Azuma S, Tasaka-Fujita M, Asahina Y, Yoneyama M, Fujita T, Watanabe M.

Hepatology. 2013; 57(1): 46-58

Frequency of Helicobacter pylori -negative gastric cancer and gastric mucosal atrophy in a Japanese endoscopic submucosal dissection series including histological, endoscopic and serological atrophy.

Ono S, Kato M, Suzuki M, Ishigaki S, Takahashi M, Haneda M, Mabe K, Shimizu Y.

Digestion. 2012; 86(1): 59-65

Endoscopic ultrasound-guided transmural drainage for pancreatic fistula or pancreatic duct dilatation after pancreatic surgery.

Onodera M, Kawakami H, Kuwatani M, Kudo T, Haba S, Abe Y, Kawahata S, Eto K, Nasu Y, Tanaka E, Hirano S, Asaka M.

Surg Endosc. 2012; 26(6): 1710-1717

A multi-center survey of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan.

Oze T, Hiramatsu N, Mita E, Akuta N, Sakamoto N, Itoh Y, Izumi N, Nomura H, Hayashi N, Takehara T.

Hepatol Res. 2013; 43(1): 35-43

Factors responsible for the discrepancy between IL28B polymorphism prediction and the viral response to peginterferon plus ribavirin therapy in Japanese chronic hepatitis C patients.

Saito H, Ito K, Sugiyama M, Matsui T, Aoki Y, Imamura M, Murata K, Masaki N, Nomura H, Adachi H, Hige S, Enomoto N, Sa-kamoto N, Kurosaki M, Mizokami M, Watanabe S.

Hepatol Res. 2012; 42(10): 958-965

Coccoid helicobacter pylori can directly adhere and invade in agminated formation to human gastric epithelial cells.

Saito N, Ooi HK, Konishi K, Shoji E, Kato M, Asaka M.

Adv Microbiol. 2012; 2(2): 112-116

Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omepra-zole-controlled randomized study (J-FOCUS).

Sakurai K, Nagahara A, Inoue K, Akiyama J, Mabe K, Suzuki J, Habu Y, Araki A, Suzuki T, Satoh K, Nagami H, Harada R, Tano N, Kusaka M, Fujioka Y, Fujimura T, Shigeto N, Oumi T, Miwa J, Miwa H, Fujimoto K, Kinoshita Y, Haruma K.

BMC Gastroenterol. 2012;12:42

Endoscopic band ligation versus argon plasma coagulation for gastric antral vascular ectasia associated with liver diseases.

Sato T, Yamazaki K, Akaike J.

Dig Endosc. 2012; 24(4): 237-242

Efficacy of endoscopic injection sclerotherapy for rectal varices.

Sato T.

J GHR. 2013; 2(1): 359-361

Virological response and safety of 24-week telaprevir alone in Japanese patients infected with hepatitis C virus subtype 1b.

Toyota J, Ozeki I, Karino Y, Asahina Y, Izumi I, Takahashi S, Kawakami Y, Chayama K, Kamiya N, Aoki K, Yamada I, Suzuki Y, Suzuki F, Kumada H.

J Viral Hepat. 2013; 20(3): 167-173

First-line sunitinib plus FOLFIRI in Japanese patients with unresectable/metastatic colorectal cancer: a phase II study.

Tsuji Y, Satoh T, Tsuji A, Muro K, Yoshida M, Nishina T, Nagase M, Komatsu Y, Kato T, Miyata Y, Mizutani N, Hashigaki S, Lechuga MJ, Denda T.

Cancer Sci. 2012; 103(8): 1502-1507

Inhibition of hepatitis C virus replication and viral helicase by ethyl acetate extract of the marine feather star Alloeocomatella poly-cladia.

Yamashita A, Abdus K, Furuta A, Matsuda Y, Fujita O, Tani H, Fujita Y, Fujimoto Y, Ikeda M, Kato N, Sakamoto N, Maekawa S, Enomoto N, Nakakoshi M, Tsubuki M, Sekiguchi Y, Thuneda S, Akimitsu N, Noda N, Tanaka J, Moriishi K.

Marine Drugs. 2012; 10(4): 744-761

TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial.

Yoshino T, Mizunuma N, Yamazaki K, Nishina T, Komatsu Y, Baba H, Tsuji A, Yamaguchi K, Muro K, Sugimoto N, Tsuji Y, Moriwaki T, Esaki T, Hamada C, Tanase T, Ohtsu A.

Lancet Oncol. 2012; 13(10): 993-1001

>